4.3 Article

Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Long-term outcomes of active surveillance for clinically localized prostate cancer in a community-based setting: results from a prospective non-interventional study

Jan Herden et al.

Summary: Long-term outcomes of patients treated with active surveillance for localized prostate cancer were investigated in a health service research study. The study found that AS can be considered a safe treatment option in routine care, with encouraging results for office-based urologists to implement AS in practice and address concerns against this treatment option.

WORLD JOURNAL OF UROLOGY (2021)

Review Endocrinology & Metabolism

Hormonal Therapy for Prostate Cancer

Kunal Desai et al.

Summary: Huggins and Hodges demonstrated the therapeutic effect of gonadal testosterone deprivation in the 1940s, leading to the concept of prostate cancer being highly androgen-dependent. Since then, hormonal therapy has evolved from gonadal testosterone deprivation to inhibiting extragonadal androgens, to directly binding and inhibiting the androgen receptor. Today's standard of care for advanced prostate cancer includes gonadotropin-releasing hormone agonists and androgen receptor antagonists.

ENDOCRINE REVIEWS (2021)

Article Biotechnology & Applied Microbiology

Genome-wide prediction and comparative transcriptomic analysis reveals the G protein-coupled receptors involved in gonadal development of Apostichopus japonicus

Dexiang Huang et al.

Summary: The study classified and analyzed G protein-coupled receptors in sea cucumbers, identifying several signaling pathways related to reproduction, including neuroactive ligand-receptor interaction, the mTOR and Wnt signaling pathways. Transcriptome analysis revealed hundreds of GPCRs expressed in the reproductive organs of sea cucumbers, with 7 ovary and 8 testis-specific GPCRs identified.

GENOMICS (2021)

Review Oncology

Metastatic Prostate Cancer: Treatment Options

Verane Achard et al.

Summary: Metastatic prostate cancer treatment has shifted with the introduction of novel therapeutic agents, requiring clinicians to choose the most appropriate treatment combination and sequence for each patient based on individual factors to optimize efficacy.

ONCOLOGY (2021)

Article Pharmacology & Pharmacy

An up-to-date evaluation of abiraterone for the treatment of prostate cancer

Jason Shpilsky et al.

Summary: Abiraterone acetate has shown significant efficacy in both castrate-sensitive and castrate-resistant metastatic prostate cancer, providing additional hormonal sensitivity for tumors resistant to ADT. When used in combination with ADT, it confers a significant overall survival benefit for patients, establishing itself as a well-tolerated, convenient, and effective treatment option with minimal additional toxicity. Ongoing studies are expected to further broaden its indications and preference among other prostate cancer therapies.

EXPERT OPINION ON PHARMACOTHERAPY (2021)

Article Biotechnology & Applied Microbiology

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling

Chengwu Gong et al.

ONCOTARGETS AND THERAPY (2019)

Review Urology & Nephrology

Current treatment strategies for advanced prostate cancer

Kazumasa Komura et al.

INTERNATIONAL JOURNAL OF UROLOGY (2018)

Article Biochemistry & Molecular Biology

Network analysis of microRNAs, transcription factors, and target genes involved in axon regeneration

Li-ning Su et al.

JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2018)

Review Oncology

Emerging Variants of Castration-Resistant Prostate Cancer

Panagiotis J. Vlachostergios et al.

CURRENT ONCOLOGY REPORTS (2017)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Endocrinology & Metabolism

NUSAP 1 Expression Is Upregulated by Loss of RB1 in Prostate Cancer Cells

Catherine A. Gordon et al.

PROSTATE (2015)

Review Oncology

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

Philip A. Watson et al.

NATURE REVIEWS CANCER (2015)

Article Medicine, General & Internal

AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer

Emmanuel S. Antonarakis et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Urology & Nephrology

Castration-Resistant Prostate Cancer: AUA Guideline

Michael S. Cookson et al.

JOURNAL OF UROLOGY (2013)

Review Cell Biology

What's Nu(SAP) in mitosis and cancer?

Jyoti Iyer et al.

CELLULAR SIGNALLING (2011)

Review Medicine, General & Internal

Characterising the castration-resistant prostate cancer population: a systematic review

M. Kirby et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)

Article Clinical Neurology

Identification of Gene Markers Associated With Aggressive Meningioma by Filtering Across Multiple Sets of Gene Expression Arrays

Jourdan E. Stuart et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)

Article Multidisciplinary Sciences

RefilinB (FAM101B) targets FilaminA to organize perinuclear actin networks and regulates nuclear shape

Olivia Gay et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Obstetrics & Gynecology

New insights into epididymal biology and function

Gail A. Cornwall

HUMAN REPRODUCTION UPDATE (2009)

Article Biochemistry & Molecular Biology

A role for NuSAP in linking microtubuies to mitotic chromosomes

Katharina Ribbeck et al.

CURRENT BIOLOGY (2007)

Article Endocrinology & Metabolism

Gene expression is differentially regulated in the epididymis after orchidectomy

N Ezer et al.

ENDOCRINOLOGY (2003)

Article Behavioral Sciences

Controlling the false discovery rate in behavior genetics research

Y Benjamini et al.

BEHAVIOURAL BRAIN RESEARCH (2001)